Form 10-Q PHIBRO ANIMAL HEALTH For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Phibro Animal Health Corp. (PAHC) PT Raised to $22 at Barclays
February 7, 2025 2:18 PM ESTBarclays analyst Balaji Prasad raised the price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $22.00 (from $20.00) while maintaining a Underweight rating.
The analyst comments "2QFY25 Rev / Adj. EPS beat cons by ~2%/~25%. Growth was led by AH (+11% excl. new MFA; +33%... More
